Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. The firm was founded in 1989, and its primary focus is on the researching and marketing of biotechnology solutions for the treatment of cystic fibrosis. The company has a number of approved therapies available that are aimed at the treatment of the underlying cause of cystic fibrosis. The company also operates advanced independent research and development programs in other areas, and has a number of investigational small molecule medicines in their pipeline, aimed at treating kidney diseases, pain, and genetic diseases such as sickle cell disease, Duchenne muscular dystrophy and Type 1 diabetes. Vertex Pharmaceuticals works in collaboration with Cystic Fibrosis Foundation Therapeutics Incorporated, CRISPR Therapeutics AG, and other organisations, and markets its products mainly to specialty healthcare providers in North America, as well as global government-owned providers. The firm has regularly been ranked as one of the industry's best places to work, including making Science Magazine's Top Employers list for 11 consecutive years, and being named a top place to work for LGBTQ equality by the Human Rights Campaign. The firm trades on the NASDAQ under the ticker VRTX. Learn more about the share price performance of VRTX on eToro.